Forbion Capital Partners

Forbion Capital Partners

Dutch venture capital firm investing on companies in the life sciences industry.

Forbion Capital Partners is a venture capital firm established in 2007. The firm was founded as a specialized private equity branch of ABN AMRO Capital, which is associated with the Netherlands-based ABN AMRO Bank. The firm’s headquarters is located in Naarden, Netherlands, with additional offices located in Munich, Germany; Tel Aviv, Israel; and Boston, Massachusetts.

Forbion Capital Partners also has a joint venture to manage seed and early-stage funds with BioGeneration Ventures. As of February 2019, Forbion Capital Partners is managing 21 companies in its portfolio and has sold off its shares in 58 companies. It has most recently funded Inflazome in November 2018, a company that specializes in developing oral drugs to manage chronic inflammatory diseases.

Funding

Forbion Capital Partners focuses on funding companies that are established in Europe (especially Austria, Germany, Switzerland, and Netherlands), Israel, and North America. The firm provides funding for companies in the field of life sciences and bio-medical technology. It gives capital to companies in various stages of development, from seed to growth stage. With its latest funding round in July 2018, the firm has managed to collect $1.2 billion in total. In the July 2018 round, the firm succeeding in amassing €360 million .

Timeline

Funded Companies

Company
Description
Website
Industry
Location

A company developing gene therapies for the treatment of genetic diseases and cancer.

A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA.

A company developing and commercializing cancer molecular diagnostics based isolation of exosomes from body fluids. Exosome Diagnostics was founded in 2008.

AM-Pharma is a biopharmaceutical company developing recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to treat patients with Acute Kidney Injury, Inflammatory Bowel Disease and Hypophosphatasia.

A biotechnology company developing immuno-oncology therapies and therapeutic vaccines

A biotechnology company that develops and commercializes biological treatments for cancer and infectious diseases

KaNDy Therapeutics is a clinical-stage company focused on optimising the potential of NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions, with an initial focus on symptoms of the menopause.

A biotechnology company developing targeted therapeutics for the treatment of fibrosis and other diseases

Mitralign is a Tewksbury, Massachusetts-based company.

Omeicos Therapeutics is a Germany-based company.

Dyne Therapeutics is a Waltham, Massachusetts-based company.

PneumRx is a healthcare company.

Oxyrane is a Burlington, Massachusetts-based company.

Escalier Biosciences is a Encinitas, California-based company.

26 Results
Page 1 of 2
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Bart Bergstein

Managing Partner

Dirk Kersten

Managing Partner

Farhang Dehzad

Employee

Geert-Jan Mulder

Managing Partner

Marco Boorsma

General Partner

Martien van Osch

Managing Partner

Sander van Deventer

Partner

Stephan Godinho Lopes Morais

Investor

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Argos Therapeutics

Inflazome

Insmed

Mitralign

NorthSea Therapeutics

OMEICOS

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.